UniQure launches $200 mln equity offering after shares skyrocket
** Netherlands-based drugmaker UniQure NV QURE.O looks to capitalize on its soaring share price by raising equity
** Its U .S.-listed shares on Weds finished up ~248% at $47.50 after co said its experimental gene therapy significantly slowed Huntington's disease progression in early-to-mid-stage trial
** It also announced early Weds it secured a $175 mln loan from Hercules Capital HTGC.N to support the potential U.S. launch of AMT-130
** After the bell, co commences $200 mln share offering, including pre-funded warrants
** Leerink Partners, Stifel, Van Lanschot Kempen and Guggenheim Secs are bookrunning managers for offering
** QURE has ~54.9 mln shares outstanding for about $2.6 bln current market cap
** U.S.-listed shares up 3.6% at $49.20 in extended trading
Related Articles
H-1B Policy Shock: Challenges for the Tech Industry and U.S. Stock Market Investments
TradingKey - The H-1B visa allows foreign professionals to work legally in the United States, primarily targeting talent in science, technology, engineering, and mathematics (STEM) fields.
U.S. August PCE: Inflation Remains the Market's Greatest Risk
Our baseline forecast anticipates sustained asset price increases. However, if inflation surpasses market expectations in the coming months, it could hinder further rate cuts and pose the greatest risk to financial markets.
Memory Giant Micron Delivers Stellar Q4 FY2025 with Explosive DRAM and HBM Growth
TradingKey - Micron Technology, Inc. (NASDAQ: MU) delivered a stellar Q4 FY2025 earnings report, exceeding expectations on revenue, earnings, and margins. The company reported total revenue of $11.32 billion, up 46% YoY and 22% sequentially, surpassing the consensus forecast of $11.1 billion.
Fed Rate Cuts: Will the Russell 2000 Outperform the S&P 500?
TradingKey - On 17 September, the Federal Reserve cut interest rates by 25 basis points, marking the official restart of the rate-cutting cycle. In theory, small-cap stocks, compared to large-cap stocks, benefit more from Fed rate cuts. This is because they are more reliant on external financing...
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.
